Cargando…
Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor
The androgen receptor (AR) is known to play a critical role in prostate cancer (PC). p53 likely also plays a role given that p53 mutations are commonly found in advanced PC, and loss of wild-type protein function contributes to the phenotype of castration-resistant prostate cancer (CRPC). Neverthele...
Autores principales: | Guseva, Natalya V., Rokhlin, Oskar W., Bair, Thomas B., Glover, Rebecca B., Cohen, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326648/ https://www.ncbi.nlm.nih.gov/pubmed/22383394 |
Ejemplares similares
-
Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015) -
Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity
por: Tewari, Alok K, et al.
Publicado: (2012) -
Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements(†)
por: Millau, Jean-François, et al.
Publicado: (2011) -
Sequence specific suppression of androgen receptor–DNA binding in vivo by a Py-Im polyamide
por: Kurmis, Alexis A, et al.
Publicado: (2019) -
Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo
por: Sahu, Biswajyoti, et al.
Publicado: (2014)